Related Experiment Video
Updated: May 26, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
Vascular effects of glycoprotein130 ligands--part I: pathophysiological role
Svitlana Demyanets1, Kurt Huber, Johann Wojta
1Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Insights
The vessel wall acts as an endocrine organ, with glycoprotein 130 (gp130) ligands modulating its function in vascular diseases. This review details the vascular effects and mechanisms of these crucial signaling molecules.
Area of Science:
- Vascular Biology
- Endocrinology
- Immunology
Background:
- The vessel wall is an active endocrine organ, not just a barrier.
- Vessel wall dysfunction is implicated in atherosclerosis, hypertension, and vasculopathies.
- Cytokines modulate vascular cell behavior, including immune, endothelial, and smooth muscle cells.
Purpose of the Study:
- To review the pathophysiological functions of glycoprotein 130 (gp130) ligands.
- To describe the vascular effects of gp130-associated cytokines.
- To discuss the molecular and cellular mechanisms underlying these vascular effects.
Main Methods:
- Literature review focusing on gp130 ligands and their vascular roles.
- Analysis of studies investigating cytokine modulation of vascular cells.
- Synthesis of information on molecular and cellular mechanisms in vascular pathophysiology.
Main Results:
- Glycoprotein 130 (gp130) is a central receptor for diverse cytokines (e.g., IL-6, OSM, LIF).
- These cytokines exert significant, varied effects on the vessel wall.
- Specific molecular and cellular pathways mediate the vascular actions of gp130 ligands.
Conclusions:
- Gp130 ligands play critical roles in vascular health and disease.
- Understanding these roles is essential for addressing vascular pathologies.
- Further research into gp130-mediated signaling can reveal therapeutic targets.
Abstract:
The vessel wall is no longer considered as only an anatomical barrier for blood cells but is recognized as an active endocrine organ. Dysfunction of the vessel wall occurs in various disease processes including atherosclerosis, hypertension, peripheral artery disease, aneurysms, and transplant and diabetic vasculopathies. Different cytokines were shown to modulate the behavior of the cells, which constitute the vessel wall such as immune cells, endothelial cells and smooth muscle cells. Glycoprotein 130 (gp130) is a common cytokine receptor that controls the activity of a group of cytokines, namely, interleukin (IL)-6, oncostatin M (OSM), IL-11, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), cardiotrophin-1 (CT-1), cardiotrophin-like cytokine (CLC), IL-27, and neuropoietin (NP). Gp130 and associated cytokines have abundantly diverse functions. Part I of this review focuses on the pathophysiological functions of gp130 ligands. We specifically describe vascular effects of these molecules and discuss the respective underlying molecular and cellular mechanisms.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Matrix Proteoglycans and Glycoproteins
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Cytotoxic Edema: Pathophysiology

